Skip to main content

Table 2 Immunohistochemical results of 21 SCC cases

From: Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases

Case No

Pathology

CK

EMA

NSE

Syn

CgA

CD56

S-100

TTF-1

1

SCC

++

+++

+++

+++

++

+++

-

+++

2

SCC

+++

++

+

++

-

+

-

-

3

SCC

++

+++

++

+++

+

+++

-

++

4

SCC

+++

++

++

++

++

++

++

+++

5

SCC

++

+++

-

+

-

+++

 

-

6

SCC

++

++

+

+++

++

++

-

+++

7

SCC

+++

++

+

++

+

+++

+

++

8

SCC

+++

++

+++

++

-

+++

-

++

9

SCC

-

-

+++

+++

++

+++

++

+++

 

SqCC

+++

++

-

-

-

-

-

-

10

SCC

-

+

+

+++

+++

-

-

++

11

SCC

-

-

-

++

-

++

-

-

12

SCC

-

-

-

++

-

-

-

+

13

SCC

-

-

++

+++

++

+++

-

-

14

SCC

++

-

+

+++

++

++

-

+++

15

SCC

+

++

-

++

++

+++

-

++

16

SCC

-

-

-

++

-

-

-

++

17

SCC

++

+++

++

+++

+

+++

+

-

18

SCC

-

++

-

-

++

-

-

+++

19

SCC

++

++

-

++

-

+++

-

-

20

SCC

-

-

+

+++

-

++

-

++

21

SCC

-

-

-

+++

+++

-

-

++

 

SqCC

+++

-

-

-

-

-

-

-

Total positive cases (%)

12(57.1)

13(61.9)

13(61.9)

20(95.2)

13(61.9)

16(76.2)

4(19.0)

15(71.4)

  1. SCC, small cell carcinoma; SqCC, squamous cell carcinoma. +, less than 10% of the tumor cells were positive; ++, 10%–50% of the tumor cells were positive; +++, more than 50% the tumor cells were positive; -, negative labeling.